Clinical validation of plasma cell-free DNA (cfDNA) sequencing in the phase 2 trial of sotorasib in patients (pts) with KRAS p.G12C mutated NSCLC Meeting Abstract
| Authors: | Bauml, J. M.; Li, B. T.; Velcheti, V.; Govindan, R.; Fontecedro, A. C.; Dooms, C.; Takahashi, T.; Duda, A. W.; Odegaard, J.; Cruz-Guilloty, F.; Jin, L.; Zhang, Y.; Skoulidis, F. |
| Abstract Title: | Clinical validation of plasma cell-free DNA (cfDNA) sequencing in the phase 2 trial of sotorasib in patients (pts) with KRAS p.G12C mutated NSCLC |
| Meeting Title: | 112th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 81 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2021 Apr 10-15/May 17-21 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2021-07-01 |
| Language: | English |
| ACCESSION: | WOS:000680263501337 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.AM2021-CT181 |
| Notes: | Meeting Abstract: CT181 -- Due to Covid 19 pandemic, the conference was held virtually -- Source: Wos |
